Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Injecting a special gel with human protein particles can help hair grow.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Caffeine and siloxanetriol alginate caffeine in emulsion form can reduce fatty cell size and number, potentially treating cellulite effectively.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Chitosan microparticles improve minoxidil sulphate delivery, potentially reducing daily applications.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Fractional laser resurfacing is effective and safe for skin treatment, with benefits like less downtime and a low risk of adverse events.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Hormonal therapies are safe and effective for treating adult women's acne.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

PRP injections improve facial skin by reducing wrinkles and pores.